Hyaluronan (HA) |
Stemness (spheroid and clone formation, self-renewal), cell growth, poor differentiation, chemoresistance |
Head and neck CSCs |
[134] |
Hyaluronan (HA) |
Cell survival, migration, poor prognosis |
Pancreatic cancer |
[135] |
Hyaluronan (HA) |
Cell motility, invasion, tumour progression |
Pleural mesothelioma |
[136] |
Hyaluronan (HA) |
Cell proliferation, poor survival |
Melanoma |
[137,138] |
Hyaluronan (HA) |
Cancer cells rolling, metastasis |
Liver cancer |
[139] |
Hyaluronan (HA) |
Cell proliferation |
Acute myeloid leukaemia |
[140] |
Osteopontin (OPN) |
Metastasis |
Bladder cancer |
[153] |
Osteopontin (OPN) |
Tumour growth, tumour recurrence, cell survival, metastasis, CSCs phenotype maintenance |
Hepatocellular carcinoma |
[154] |
Osteopontin (OPN) |
Invasion |
Pancreatic cancer |
[136,156] |
Osteopontin (OPN) |
Tumour progression and recurrence |
Ovarian cancer |
[157] |
Osteopontin (OPN) |
Migration |
Breast cancer |
[158] |
Osteopontin (OPN) |
Radio-resistance |
Colorectal carcinoma |
[159] |
Osteopontin (OPN) |
Tumour immune evasion |
Colon carcinoma |
[160] |
Osteopontin (OPN) |
Cell proliferation |
Lung cancer |
[161] |
Osteopontin (OPN) |
Aggressive growth, stemness, radio-resistance |
Glioma CSCs |
[80] |
Osteopontin (OPN) |
Tumour progression, metastasis |
Gastric cancer |
[162] |
Matrix metalloproteinase14 (MMP-14) |
Migration |
Pancreatic cancer, breast cancer, osteosarcoma |
[164] |
Matrix metalloproteinase14 (MMP-14) |
Invasion, migration |
Colon carcinoma |
[165] |
Matrix metalloproteinase 14 (MMP-14) |
Poor prognosis |
Ovarian cancer |
[166] |
Matrix metalloproteinase 14 (MMP-14) |
Poor prognosis, invasion |
Breast cancer |
[167] |
Matrix metalloproteinase 9 (MMP-9) |
Cell adhesion, invasion, migration |
Glioblastoma |
[171] |
Matrix metalloproteinase 9 (MMP-9) |
Invasion, metastasis stage |
Renal carcinoma |
[175] |
Matrix metalloproteinase 9 (MMP-9) |
Invasion, migration, sphere formation |
Prostate cancer |
[177] |
Matrix metalloproteinase 2 (MMP-2) |
Lymph node metastasis, histopathological grade, TNM stage, poor prognosis |
Non-small cell lung cancer |
[173] |
Matrix metalloproteinase 2,9 (MMP-2), (MMP-9) |
Invasion |
Breast cancer |
[174] |